Activation profile of pro-inflammatory cytokines in acute cardiac overload;Perfil da activação das citocinas pró- inflamatórias na sobrecarga cardíaca aguda

Revista Portuguesa de Cardiologia

Volumn 24, Issue 11, 2005, Pages 1369-1378

  Roncon Albuquerque Jr , Roberto ^a   Vasconcelos, Mariana ^a   Lourenço, André P ^a   Brandão Nogueira, Ana ^a   Teles, Antónia ^a   Faria, Bernardo ^a   Henriques Coelho, Tiago ^a   Leite Moreira, Adelino F ^a  

^a UNIVERSITY OF PORTO   (Portugal)

Author keywords

Gene expression; Interleukin 6; Mechanotransduction; Tumor necrosis factor alpha

Indexed keywords

CYTOKINE; DEXTRAN 40; INTERLEUKIN 6; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORRELATION COEFFICIENT; CYTOKINE PRODUCTION; DISEASE COURSE; GENE ACTIVATION; GENE EXPRESSION; HEART FAILURE; HEART HEMODYNAMICS; HEART RIGHT VENTRICLE PRESSURE; HEART RIGHT VENTRICLE VOLUME; HEART VENTRICLE OVERLOAD; HEART VENTRICLE WALL; INFLAMMATION; MALE; MANOMETER; MECHANOTRANSDUCTION; NONHUMAN; RAT; SYSTOLIC BLOOD PRESSURE;

ANIMALS; GENE EXPRESSION; HEART VENTRICLES; HEMODYNAMIC PROCESSES; INTERLEUKIN-6; MALE; MYOCARDIUM; RATS; RATS, WISTAR; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 30944447479     PISSN: 08702551     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Hoshijima M, Chien KR. Mixed signals in heart failure: cancer rules. J Clin Invest 2002;109:849-55.
2. Sussman MA, McCulloch A, Borg TK. Dance band on the Titanic: biochemical signaling in cardiac hypertrophy. Circ Res 2002;91:888-98.
3. Morisco C, Sadoshima J, Trimarco B, Arora R, Vatner DE, Vatner SF. Is treating cardiac hypertrophy salutary or detrimental: the two faces of Janus. Am J Physiol Heart Circ Physiol 2003;284:H1043-7.
4. Smith RM, Lecour S, Sack MN. Innate immunity and cardiac preconditioning: a putative intrinsic cardioprotective program. Cardiovasc Res 2002;55:474-482.
5. Kubota T, McTiernan CF, Frye CS, Slawson SE, Lemster BH, Koretsky AP, Demetris AJ, Feldman AM. Dilated cardiomyopathy in transgenic mice with cardiac specific overexpression of tumor necrosis factor-alpha. Circ Res 1997;81:627-635.
6. Sivasubramanian N, Coker ML, Kurrelmeyer KM, MacLellan WR, DeMayo FJ, Spinale FG, Mann DL. Left ventricular remodeling in transgenic mice with cardiac restricted overexpression of tumor necrosis factor. Circulation 2001;2001:826-31.
7. Kapadia SR, Oral H, Lee J, Nakano M, Taffet GE, Mann DL. Hemodynamic regulation of tumor necrosis factor-alpha expression in adult feline myocardium. Circ Res 1997;81:187-195.
8. Kapadia S, Lee J, Torre-Amione G, Birdsall HH, Ma TS, Mann DL. Tumor necrosis factor-alpha and protein expression in adult feline myocardium after endotoxin administration. J Clin Invest 1995;96:1042-52.
9. Mann DL. Stress-activated cytokines and the heart: from adaptation to maladaptation. Ann Rev Physiol 2003;65:81-101.
10. Baumgarten G, Knuefermann P, Kalra D, Gao F, Taffet GE, Michael L, Blackshear PJ, Carballo E, Sivasubramanian N, Mann DL. Load-dependent and -independent regulation of proinflammatory cytokine and cytokine receptor gene expression in the adult mammalian heart. Circulation 2002;105:2192-7.
11. Modesti PA, Vanni S, Bertolozzi I, Cecioni I, Lumachi C, Perna AM, Boddi M, Gensini GF. Different growth factor activation in the right and left ventricles in experimental volume overload. Hypertension 2004;43:101-8.
12. Wollert KC, Taga T, Saito M, Narazaki M, Kishimoto T, Glembotski CC, Vernallis AB, Heath JK, Pennica D, Wood WI, Chien KR. Cardiotrophin-1 activates a distinct form of cardiac muscle cell hypertrophy. Assembly of sarcomeric units in series VIA gp130/leukemia inhibitory factor receptor-dependent pathways. J Biol Chem 1996;271:9535-45.
13. Nian M, Lee P, Khaper N, Liu P. Inflammatory cytokines and postmyocardial infarction remodeling. Circ Res 2004;94:1543-53.
14. Frangogiannis NG, Smith CW, Entman ML. The inflammatory response in myocardial infarction. Cardiovasc Res 2002;53:31-47.
15. Nakamura H, Umemoto S, Naik G, Moe G, Takata S, Liu P, Matsuzaki M. Induction of left ventricular remodeling and dysfunction in the recipient after donor heart myocardial infarction: new insights into the pathologic role of tumor necrosis factor-alpha from a novel heterotopic transplant-coronary ligation rat model. J Am Coll Cardiol 2003;42:173-81.
16. Dai RP, Dheen ST, He BP, Tay SSW. Differential expression of cytokines in the rat heart in response to sustained volume overload. Eur J Heart Fail 2004;6:693-703.
17. Palmieri EA, Benincasa G, Di Rella F, Casaburi C, Monti MG, De Simone G, Chiariotti L, Palombini L, Bruni CB, Sacca L, Cittadini A. Differential expression of TNF-alpha, IL-6 and IGF-1 by graded mechanical stress in normal rat myocardium. Am J Physiol Heart Circ Physiol 2002;282:H926-34.
18. van Wamel AJ, Ruwhof C, van der Valk-Kokshoorn LJ, Schrier PI, van der Laarse A. Rapid effects of stretched myocardial and vascular cells on gene expression of neonatal rat cardiomyocytes with emphasis on autocrine and paracrine mechanisms. Arch Biochem Biophys 2000;381:67-73.
19. Vasan RS, Sullivan LM, Roubenoff R, Dinarello CA, Harris T, Benjamin EJ, Sawyer DB, Levy D, Wilson PW, D'Agostino RB. Inflammatory markers and risk of heart failure in elderly subjects without prior myocardial infarction: the Framingham Heart Study. Circulation 2003;107:1486-91.
20. Gullestad L, Aukrust P. Review of trials in chronic heart failure showing broad-spectrum anti-inflammatory approaches. Am J Cardiol 2005;95:17C-23C.
21. Mann DL, McMurray JJ, Packer M, Swedberg K, Borer JS, Colucci WS, Djian J, Drexler H, Feldman A, Kober L, Krum H, Liu P, Nieminen M, Tavazzi L, van Veldhuisen DJ, Waldenstrom A, Warren M, Westheim A, Zannad F, Fleming T. Targeted anticytokine therapy in patients with chronic heart failure: results of the Randomized Etanercept Worldwide Evaluation (RENEWAL). Circulation 2004;109:1594-602.